These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32252866)

  • 1. HIV research in South Africa: Advancing life.
    Gray G; Doherty T; Mohapi L; Coetzee J; Hopkins KL; Malahleha M; Lazarus E; Dietrich J; Pillay-van Wyk V; Laher F
    S Afr Med J; 2019 Dec; 109(11b):36-40. PubMed ID: 32252866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent efforts in biomedical prevention of HIV.
    Landovitz RJ
    Top HIV Med; 2007; 15(3):99-103. PubMed ID: 17598929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis.
    Abuelezam NN; McCormick AW; Fussell T; Afriyie AN; Wood R; DeGruttola V; Freedberg KA; Lipsitch M; Seage GR
    Am J Epidemiol; 2016 Aug; 184(3):239-48. PubMed ID: 27416841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maximising HIV prevention by balancing the opportunities of today with the promises of tomorrow: a modelling study.
    Smith JA; Anderson SJ; Harris KL; McGillen JB; Lee E; Garnett GP; Hallett TB
    Lancet HIV; 2016 Jul; 3(7):e289-96. PubMed ID: 27365203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV Prevention in a Time of COVID-19: A Report from the HIVR4P // Virtual Conference 2021.
    Laher F; Richardson SI; Smith P; Sullivan PS; Abrahams AG; Asowata OE; Bitangumutwenzi P; Dabee S; Dollah A; Fernandez N; Langat RK; Bose DL; Likhitwonnawut U; Mullick R; Resop RS; Sutar J; Thompson-Hall AN; Traeger MW; Tuyishime M; Wambui J; Bekker LG; Kaleebu P; McCormack S; O'Connor DH; Warren M; Torri T; Thyagarajan B
    AIDS Res Hum Retroviruses; 2022 May; 38(5):350-358. PubMed ID: 34714100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not if but how? Caring for HIV-1 vaccine trial participants in South Africa.
    Tucker T; Slack C
    Lancet; 2003 Sep; 362(9388):995. PubMed ID: 14513854
    [No Abstract]   [Full Text] [Related]  

  • 7. Uptake of biomedical interventions for prevention of sexually transmitted HIV.
    Abbas UL
    Curr Opin HIV AIDS; 2011 Mar; 6(2):114-8. PubMed ID: 21505385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approaches to HIV prevention.
    Highleyman L
    BETA; 2007; 19(2):29-38. PubMed ID: 17489114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial prevention of HIV transmission in women: the case for a vaginal microbicide.
    Bélec L; Jenabian MA; Charpentier C; Saïdi H
    Future Microbiol; 2011 Jul; 6(7):731-7. PubMed ID: 21797688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for HIV control in South Africa: a model-based analysis.
    Johnson LF; Chiu C; Myer L; Davies MA; Dorrington RE; Bekker LG; Boulle A; Meyer-Rath G
    Glob Health Action; 2016; 9():30314. PubMed ID: 27282146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomedical methods for HIV prevention: new setbacks.
    Laurence J
    AIDS Read; 2008 Apr; 18(4):163-4. PubMed ID: 18472438
    [No Abstract]   [Full Text] [Related]  

  • 13. How low can you go: the impact of a modestly effective HIV vaccine compared with male circumcision.
    Kaldor JM; Wilson DP
    AIDS; 2010 Oct; 24(16):2573-8. PubMed ID: 20829677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomedical methods for preventing the sexual transmission of HIV.
    McCoy SI; Padian NS
    Focus; 2010 Dec; 24(4):1-4. PubMed ID: 21244108
    [No Abstract]   [Full Text] [Related]  

  • 15. Pre-exposure prophylaxis for South African adolescents: What evidence?
    Bekker LG; Gill K; Wallace M
    S Afr Med J; 2015 Nov; 105(11):907-11. PubMed ID: 26632316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbicide research in developing countries: have we given the ethical concerns due consideration?
    Moodley K
    BMC Med Ethics; 2007 Sep; 8():10. PubMed ID: 17877834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV prevention today: with coordinated action, we can end transmission.
    Saxton PJ; Hughes AJ; Giola M
    N Z Med J; 2015 Dec; 128(1426):8-15. PubMed ID: 26913903
    [No Abstract]   [Full Text] [Related]  

  • 18. Joining forces.
    Willyard C
    Nature; 2010 Jul; 466(7304):S9-10. PubMed ID: 20631707
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenesis of HIV disease: opportunities for new prevention interventions.
    Fauci AS
    Clin Infect Dis; 2007 Dec; 45 Suppl 4():S206-12. PubMed ID: 18190288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials.
    Rudy BJ; Kapogiannis BG; Lally MA; Gray GE; Bekker LG; Krogstad P; McGowan I
    J Acquir Immune Defic Syndr; 2010 Jul; 54 Suppl 1(Suppl 1):S31-42. PubMed ID: 20571421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.